Trading Statements
![shutterstock_528756874.jpg](/globalassets/investor-relations/public/generic-ineos-imagery/shutterstock_528756874.jpg)
Trading Statement Q4, 2024
20 jan 2025
![shutterstock_255383656.jpg](/globalassets/investor-relations/public/generic-ineos-imagery/shutterstock_255383656.jpg)
Trading Statement Q3, 2024
18 okt 2024
![shutterstock_421890220.jpg](/globalassets/investor-relations/public/generic-ineos-imagery/shutterstock_421890220.jpg)
Trading Statement Q2, 2024
19 jul 2024
![shutterstock_443123731.jpg](/globalassets/investor-relations/public/generic-ineos-imagery/shutterstock_443123731.jpg)
Trading Statement Q1, 2024
19 apr 2024
![shutterstock_516311050.jpg](/globalassets/investor-relations/public/generic-ineos-imagery/shutterstock_516311050.jpg)
Trading Statement Q4, 2023
19 jan 2024
![shutterstock_599785391.jpg](/globalassets/investor-relations/public/generic-ineos-imagery/shutterstock_599785391.jpg)
Trading Statement Q3, 2023
20 okt 2023
![shutterstock_12373195.jpg](/globalassets/investor-relations/public/generic-ineos-imagery/shutterstock_12373195.jpg)
Q2, 2023 Trading Statement
20 jul 2023
![shutterstock_566626918.jpg](/globalassets/investor-relations/public/generic-ineos-imagery/shutterstock_566626918.jpg)
Trading Statement Q1, 2023
21 apr 2023
![shutterstock_631274768.jpg](/globalassets/investor-relations/public/generic-ineos-imagery/shutterstock_631274768.jpg)
Trading Statement Q4, 2022
03 feb 2023